2186 on Hong Kong Stock Exchange
Luye Pharma Group Limited
Its shares trade on Hong Kong Stock Exchange under the symbol 2186.1
Price unavailable
Last updated Oct 21, 2026.
Overview
- Ticker2186 on Hong Kong Stock Exchange1
- Websitewww.luye.cn
Timeline
- Jul 9, 2014Went public Listed on Hong Kong Stock Exchange1
Calendar
Drug trials and FDA: coming up
- Feb 28, 2027Phase 4 trial readout expected Phase 4 trial of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Major Depressive Disorder: primary completion expected Feb 28, 2027 (ClinicalTrials.gov NCT06426485).2
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar
Links
- Websitewww.luye.cn1
- WikidataQ15942252
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2